Various factors are reported to affect the risk of local recurrence after resection of colorectal liver metastases. This article discusses the findings of a recent study that investigated the effect of fatty liver disease on the risk of recurrence.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cytotoxic activity of the twigs of Cinnamomum cassia through the suppression of cell proliferation and the induction of apoptosis in human colorectal cancer cells
BMC Complementary and Alternative Medicine Open Access 25 January 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Paradis, V. et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 49, 851–859 (2009).
Vauthey, J. N. et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J. Clin. Oncol. 24, 2065–2072 (2006).
Hamady, Z. Z. et al. Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases. Br. J. Surg. http://dx.doi.org/10.1002/bjs.9057.
VanSaun, M. N., Lee, I. K., Washington, M. K., Matrisian, L. & Gorden, D. L. High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Am. J. Pathol. 175, 355–364 (2009).
Angliviel, B. et al. Impact of chemotherapy on the accuracy of computed tomography scan for the evaluation of colorectal liver metastases. Ann. Surg. Oncol. 16, 1247–1253 (2009).
Kooby, D. A. et al. Impact of steatosis on perioperative outcome following hepatic resection. J. Gastrointest. Surg. 7, 1034–1044 (2003).
Tamandl, D. et al. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy. Ann. Surg. Oncol. 18, 421–430 (2011).
Nordlinger, B. et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371, 1007–1016 (2008).
Sorbye, H. et al. Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann. Surg. 255, 534–539 (2012).
Brouquet, A. et al. Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 145, 362–371 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Brouquet, A., Nordlinger, B. Metastatic colorectal cancer outcome and fatty liver disease. Nat Rev Gastroenterol Hepatol 10, 266–267 (2013). https://doi.org/10.1038/nrgastro.2013.53
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2013.53
This article is cited by
-
Cytotoxic activity of the twigs of Cinnamomum cassia through the suppression of cell proliferation and the induction of apoptosis in human colorectal cancer cells
BMC Complementary and Alternative Medicine (2018)
-
Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells
Tumor Biology (2016)
-
Adjuvant Therapy in Combination with Resection of Colorectal Cancer Metastasis to the Liver or Lungs
Current Colorectal Cancer Reports (2014)
